203 related articles for article (PubMed ID: 18222210)
21. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
[TBL] [Abstract][Full Text] [Related]
22. The "best operation" for esophageal cancer?
Pennathur A; Zhang J; Chen H; Luketich JD
Ann Thorac Surg; 2010 Jun; 89(6):S2163-7. PubMed ID: 20494003
[TBL] [Abstract][Full Text] [Related]
23. Surgical management of esophageal carcinoma.
Reed CE
Oncologist; 1999; 4(2):95-105. PubMed ID: 10337379
[TBL] [Abstract][Full Text] [Related]
24. What is appropriate treatment for carcinoma of the thoracic esophagus?
Law S; Wong J
World J Surg; 2001 Feb; 25(2):189-95. PubMed ID: 11338021
[TBL] [Abstract][Full Text] [Related]
25. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.
Woodard GA; Crockard JC; Clary-Macy C; Zoon-Besselink CT; Jones K; Korn WM; Ko AH; Gottschalk AR; Rogers SJ; Jablons DM
J Surg Oncol; 2016 Dec; 114(7):838-847. PubMed ID: 27569043
[TBL] [Abstract][Full Text] [Related]
26. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer.
Shaikh T; Meyer JE; Horwitz EM
Surg Oncol Clin N Am; 2017 Jul; 26(3):405-429. PubMed ID: 28576180
[TBL] [Abstract][Full Text] [Related]
27. Esophagus cancer.
Seitz JF; Dahan L; Jacob J; Artru P; Maingon P; Bedenne L; Triboulet JP
Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S5-2S15. PubMed ID: 17151558
[No Abstract] [Full Text] [Related]
28. Comparison of Endoscopic Resection and Minimally Invasive Esophagectomy in Patients With Early Esophageal Cancer.
Jin XF; Gai W; Chai TH; Li L; Guo JQ
J Clin Gastroenterol; 2017 Mar; 51(3):223-227. PubMed ID: 27306943
[TBL] [Abstract][Full Text] [Related]
29. Minimally Invasive Salvage Operations for Esophageal Cancer after Definitive Chemoradiotherapy.
Nakajima M; Kato H; Muroi H; Kikuchi M; Takahashi M; Yamaguchi S; Sasaki K; Ishikawa H; Sakurai H; Kuwano H
Digestion; 2018; 97(1):64-69. PubMed ID: 29393232
[TBL] [Abstract][Full Text] [Related]
30. Chemoradiotherapy in esophageal cancer: toxicity is in the eye of the beholder.
Ilson DH
J Thorac Oncol; 2009 Mar; 4(3):277-8. PubMed ID: 19247080
[No Abstract] [Full Text] [Related]
31. Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment.
Lu SL; Hsu FM; Tsai CL; Lee JM; Huang PM; Hsu CH; Lin CC; Chang YL; Hsieh MS; Cheng JC
Eur J Surg Oncol; 2019 Aug; 45(8):1498-1504. PubMed ID: 30910457
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of surgical resection for the recurrence of esophageal cancer after radical esophagectomy.
Hiyoshi Y; Morita M; Kawano H; Otsu H; Ando K; Ito S; Miyamoto Y; Sakamoto Y; Saeki H; Oki E; Ikeda T; Baba H; Maehara Y
Ann Surg Oncol; 2015 Jan; 22(1):240-6. PubMed ID: 25124469
[TBL] [Abstract][Full Text] [Related]
33. Local recurrence after total or subtotal esophagectomy for esophageal cancer.
Blewett CJ; Miller JD; Ramlawi B; Young JE; BennettWF ; Urschel JD
J Exp Clin Cancer Res; 2001 Mar; 20(1):17-9. PubMed ID: 11370823
[TBL] [Abstract][Full Text] [Related]
34. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
[TBL] [Abstract][Full Text] [Related]
35. Survival After Esophagectomy: A Propensity-Matched Study of Different Surgical Approaches.
Weksler B; Sullivan JL
Ann Thorac Surg; 2017 Oct; 104(4):1138-1146. PubMed ID: 28760463
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.
Urschel JD; Vasan H
Am J Surg; 2003 Jun; 185(6):538-43. PubMed ID: 12781882
[TBL] [Abstract][Full Text] [Related]
37. Trends in Treatment of T1N0 Esophageal Cancer.
Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
[TBL] [Abstract][Full Text] [Related]
38. [Salvage surgery in esophageal cancer : Feasibility in patients after definitive radiochemotherapy (> 50 Gy)].
Schmidt T; Sisic L; Sterzing F; Haag GM; Kunzmann R; Grenacher L; Weichert W; Jäger D; Büchler MW; Ott K
Chirurg; 2015 Oct; 86(10):955-62. PubMed ID: 25715974
[TBL] [Abstract][Full Text] [Related]
39. Triple modality (neoadjuvant chemoradiotherapy followed by surgical resection): is it better than definitive chemoradiation therapy in cancer of the thoracic esophagus?
Schefter TE; Gaspar LE
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):581-2. PubMed ID: 11872309
[No Abstract] [Full Text] [Related]
40. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
